Correction: Outcomes among newly diagnosed AL amyloidosis patients with a very high NT-proBNP: implications for trial design.
Vaxman I, Kumar SK, Buadi F, Lacy MQ, Dingli D, Hwa Y, Fonder A, Hobbs M, Hayman S, Kourelis T, Warsame R, Muchtar E, Leung N, Kapoor P, Grogan M, Go R, Lin Y, Gonsalves W, Siddiqui M, Kyle RA, Rajkumar SV, Gertz MA, Dispenzieri A.
Vaxman I, et al. Among authors: kumar sk.
Leukemia. 2024 Aug;38(8):1866. doi: 10.1038/s41375-024-02311-w.
Leukemia. 2024.
PMID: 38886493
Free PMC article.
No abstract available.